A new documentary, 'The Pink Pill: Sex, Drugs and Who Has Control,' explores the fight to bring the women’s sexual health pill, Addyi, to market Addyi; Catalyst Works The new documentary, The Pink ...

The Food and Drug Administration (FDA) is considering possible regulatory action, due to a spike in reported adverse events associated with the drug Addyi (flibanserin), which is indicated for ...

Sprout Pharmaceuticals' female libido drug Addyi has traveled a winding path through FDA gatekeepers, multiple M&A deals, marketing restrictions and more. With a possible new safety flag, the ...

In a little noticed move, the company that sells the Addyi pill for female sexual dysfunction recently won regulatory approval in Canada, thanks to a followup study designed to address a nagging ...

Add Yahoo as a preferred source to see more of our stories on Google. Viagra, the little blue pill, has been a household name for more than a generation. And now women’s sexual health is finally ...

Four years after approving the controversial Addyi pill for female sexual dysfunction, the Food and Drug Administration on Thursday softened a safety warning about mixing the drug with alcohol. But ...

WASHINGTON -- The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to ...

Three years ago, the holy grail for women with a low sex drive seemed to have arrived. A little pink pill called Addyi—pronounced add-ee and erroneously nicknamed the female Viagra—was the first ...

Sprout Pharmaceuticals failed to include drug risk information in a promotional social media post, the FDA said in a warning letter posted on Tuesday. The agency said the company's CEO Cindy Eckert ...

In the often unspoken world of female sexual health, a revolution has started, and it began with the introduction of a unique medication called Addyi. Traditionally, when we think of sexual ...

Credit: Sprout Pharmaceuticals The approval was based on a randomized, double-blind, placebo-controlled phase 3 trial, which included 447 postmenopausal women with acquired, generalized HSDD.

Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally entering the long-overdue conversation. The FDA recently approved the use ...